Search Results - "Wood, David P."

Predicting 15-year prostate cancer specific mortality after radical prostatectomy by Eggener, Scott E, Scardino, Peter T, Walsh, Patrick C, Han, Misop, Partin, Alan W, Trock, Bruce J, Feng, Zhaoyong, Wood, David P, Eastham, James A, Yossepowitch, Ofer, Rabah, Danny M, Kattan, Michael W, Yu, Changhong, Klein, Eric A, Stephenson, Andrew J

“…Long-term prostate cancer specific mortality after radical prostatectomy is poorly defined in the era of widespread screening. An understanding of the treated…”
Get more information

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial by Messing, Edward M, Tangen, Catherine M, Lerner, Seth P, Sahasrabudhe, Deepak M, Koppie, Theresa M, Wood, David P, Mack, Philip C, Svatek, Robert S, Evans, Christopher P, Hafez, Khaled S, Culkin, Daniel J, Brand, Timothy C, Karsh, Lawrence I, Holzbeierlein, Jeffrey M, Wilson, Shandra S, Wu, Guan, Plets, Melissa, Vogelzang, Nicholas J, Thompson, Ian M

“…IMPORTANCE: Low-grade non–muscle-invasive urothelial cancer frequently recurs after excision by transurethral resection of bladder tumor (TURBT). OBJECTIVE: To…”
Get full text

Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era by STEPHENSON, Andrew J, KATTAN, Michael W, EASTHAM, James A, BIANCO, Fernando J, YOSSEPOWITCH, Ofer, VICKERS, Andrew J, KLEIN, Eric A, WOOD, David P, SCARDINO, Peter T

“…The long-term risk of prostate cancer-specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread…”
Get full text

Prediction of Erectile Function Following Treatment for Prostate Cancer by Alemozaffar, Mehrdad, Regan, Meredith M, Cooperberg, Matthew R, Wei, John T, Michalski, Jeff M, Sandler, Howard M, Hembroff, Larry, Sadetsky, Natalia, Saigal, Christopher S, Litwin, Mark S, Klein, Eric, Kibel, Adam S, Hamstra, Daniel A, Pisters, Louis L, Kuban, Deborah A, Kaplan, Irving D, Wood, David P, Ciezki, Jay, Dunn, Rodney L, Carroll, Peter R, Sanda, Martin G

“…CONTEXT Sexual function is the health-related quality of life (HRQOL) domain most commonly impaired after prostate cancer treatment; however, validated tools…”
Get full text

Renal Mass Core Biopsy: Accuracy and Impact on Clinical Management by Maturen, Katherine E, Nghiem, Hanh V, Caoili, Elaine M, Higgins, Ellen G, Wolf, J. Stuart, Jr, Wood, David P., Jr

“…The objective of our study was to determine the accuracy of imaging-guided percutaneous renal mass biopsy and its impact on clinical management. With…”
Get full text

Accuracy of Percutaneous Core Biopsy in Management of Small Renal Masses by Wang, Rou, Wolf, J. Stuart, Wood, David P, Higgins, Ellen J, Hafez, Khaled S

“…Objectives To determine the sufficiency and accuracy of percutaneous core needle renal biopsy in patients with small renal masses (SRMs). Methods A…”
Get full text

Delays in diagnosis and bladder cancer mortality by Hollenbeck, Brent K., Dunn, Rodney L., Ye, Zaojun, Hollingsworth, John M., Skolarus, Ted A., Kim, Simon P., Montie, James E., Lee, Cheryl T., Wood, David P., Miller, David C.

“…BACKGROUND: Mortality from invasive bladder cancer is common, even with high‐quality care. Thus, the best opportunities to improve outcomes may precede the…”
Get full text

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer by Grossman, H. Barton, Natale, Ronald B, Tangen, Catherine M, Speights, V.O, Vogelzang, Nicholas J, Trump, Donald L, White, Ralph W. deVere, Sarosdy, Michael F, Wood, David P, Raghavan, Derek, Crawford, E. David

“…In this study of patients with locally advanced bladder cancer, the result of treatment with chemotherapy (methotrexate, vinblastine, doxorubicin, and…”
Get full text

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study by DORFF, Tanya B, FLAIG, Thomas W, VOGELZANG, Nicholas J, THOMPSON, Ian M, GLODE, L. Michael, TANGEN, Catherine M, HUSSAIN, Maha H. A, SWANSON, Gregory P, WOOD, David P, SAKR, Wael A, DAWSON, Nancy A, HAAS, Naomi B, CRAWFORD, E. David

“…Men with high-risk features (extraprostatic extension or high Gleason grade) face a high risk of prostate cancer recurrence after radical prostatectomy…”
Get full text

Matched Comparison of Robotic-assisted and Open Radical Cystectomy by Styn, Nicholas R, Montgomery, Jeffery S, Wood, David P, Hafez, Khaled S, Lee, Cheryl T, Tallman, Christopher, He, Chang, Crossley, Heather, Hollenbeck, Brent K, Weizer, Alon Z

“…Objective To evaluate our initial robotic-assisted radical cystectomy (RARC) experience compared with a robust open radical cystectomy (ORC) series performed…”
Get full text

Re: A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results by Wood, David P

Get more information

Re: Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy by Wood, David P

Get more information

Five year Expanded Prostate cancer Index Composite‐based quality of life outcomes after prostatectomy for localized prostate cancer by Parker, Walter R., Wang, Rou, He, Chang, Wood Jr, David P.

“…Study Type – Therapy (outcomes research) Level of Evidence 2c What’s known on the subject? and What does the study add? Previous studies typically assessed…”
Get full text

Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival by Lee, Cheryl T, Madii, Rabii, Daignault, Stephanie, Dunn, Rodney L, Zhang, Yingxi, Montie, James E, Wood, Jr, David P

“…Some groups hypothesize that a delay in cystectomy may result in higher pathological stage and possibly alter survival in patients with bladder cancer. The…”
Get more information

Re: Prospective Evaluation of a Preoperative Biomarker Panel for Prediction of Upstaging at Radical Cystectomy by Wood, David P., MD

Get full text

Do Margins Matter? The Influence of Positive Surgical Margins on Prostate Cancer–Specific Mortality by Stephenson, Andrew J, Eggener, Scott E, Hernandez, Adrian V, Klein, Eric A, Kattan, Michael W, Wood, David P, Rabah, Danny M, Eastham, James A, Scardino, Peter T

“…Abstract Background Positive surgical margins (PSMs) in radical prostatectomy (RP) specimens are a frequent indication for adjuvant radiotherapy and are used…”
Get full text

Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) by Gilbert, Scott M., Wood, David P., Dunn, Rodney L., Weizer, Alon Z., Lee, Cheryl T., Montie, James E., Wei, John T.

“…BACKGROUND. Health‐related quality of life (HRQOL) has not been adequately measured in bladder cancer. A recently developed reliable and disease‐specific…”
Get full text

Body Image and Bladder Cancer Specific Quality of Life in Patients With Ileal Conduit and Neobladder Urinary Diversions by Hedgepeth, Ryan C, Gilbert, Scott M, He, Chang, Lee, Cheryl T, Wood, David P

“…Purpose Patients undergoing radical cystectomy with neobladder for bladder cancer are hypothesized to tolerate worse urinary function than ileal conduit…”
Get full text

Re: current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS) by Wood, David P

Get more information

Re: recurrence of high-risk bladder cancer: a population-based analysis by Wood, David P

Get more information